Patent details
EP3829551 Title: CRYSTALLINE EPINEPHRINE MALONATE SALT
Basic Information
- Publication number:
- EP3829551
- PCT Application Number:
- US2019043856
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP198453433
- PCT Publication Number:
- WO2020028215
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE EPINEPHRINE MALONATE SALT
- French Title of Invention:
- SEL DE MALONATE D'ÉPINÉPHRINE CRISTALLIN
- German Title of Invention:
- KRISTALLINES EPINEPHRINMALONATSALZ
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 26/01/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 08/02/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 03/01/2024
- Unitary Effect Registration Date:
- 08/02/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 29/07/2019
- Grant date:
- 03/01/2024
- EP Publication Date:
- 09/06/2021
- PCT Publication Date:
- 06/02/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/01/2024
- EP B1 Publication Date:
- 03/01/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 29/07/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/01/2024
- Name:
- Biothea Pharma, Inc.
- Address:
- 2 Avery Street Suite 21E, Boston, MA 02111, United States (US)
History of Owners
- From:
- 27/12/2023
- To:
- 12/01/2024
- Name:
- Biothea Pharma, Inc.
- Address:
- 125 Summer Street Suite 1675, Boston, Massachusetts 02110, United States (US)
Inventor
1
- Name:
- MOUSSA, Adel
- Address:
- United States (US)
2
- Name:
- SOMMADOSSI, Jean-Pierre
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201862711936 P
- Priority Date:
- 30/07/2018
- Priority Country:
- United States (US)
2
- Priority Number:
- 201862731442 P
- Priority Date:
- 14/09/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07C 55/08; C07C 215/60; A61K 31/00; A61K 31/137; A61K 47/12;
Publication
European Patent Bulletin
1
- Issue number:
- 202401
- Publication date:
- 03/01/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202407
- Publication date:
- 14/02/2024
- Description:
- Change of owner's name or address
3
- Issue number:
- 202410
- Publication date:
- 06/03/2024
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202411
- Publication date:
- 13/03/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|